arginine vasopressin has been researched along with acetylcysteine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Feng, ZP; Gong, HD; Li, K; Liu, YW; Ou, YC; Peng, JJ; Qi, ST; Qiu, BH; Wang, YJ; Zhou, MF | 1 |
1 review(s) available for arginine vasopressin and acetylcysteine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for arginine vasopressin and acetylcysteine
| Article | Year |
|---|---|
Endoplasmic reticulum stress induces apoptosis of arginine vasopressin neurons in central diabetes insipidus via PI3K/Akt pathway.
Topics: Acetylcysteine; Animals; Apoptosis; Arginine Vasopressin; Diabetes Insipidus, Neurogenic; Disease Models, Animal; Endoplasmic Reticulum Stress; Hypothalamus; Male; MAP Kinase Signaling System; Neurons; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation; Rats, Sprague-Dawley | 2019 |